FUNCTIONAL SIGNIFICANCE OF SULFATED GLYCOSAMINOGLYCAN COMPLEX FOR THE CONTROL OF FIBROBLAST PROLIFERATION IN VITRO

Khristo Periklovich Takhchidi; Sergey Viktorovich Novikov; Anna Viktorovna Shatskikh; Elena Khristovna Takhchidi; Kseniya Sergeevna Gorbunova; Kh P Takhchidi; S V Novikov; A V Shatzkikh; Ye Kh Takhchidi; K S Gorbunova

doi:10.17816/morph.398558

Morphology ›› 2012, Vol. 142 ›› Issue (5) : 49 -54. DOI: 10.17816/morph.398558

Articles

other

FUNCTIONAL SIGNIFICANCE OF SULFATED GLYCOSAMINOGLYCAN COMPLEX FOR THE CONTROL OF FIBROBLAST PROLIFERATION IN VITRO

Author information +

History +

PDF

Abstract

The effect of an original sulfated glycosaminoglycan (sGAG) mixture (keratan sulfate with chondroitin sulfate) was examined in the in vitro experiment with the cell culture of murine fibroblasts (cell line L929).Two forms (solution and gel) of the active substance were tested in different concentrations (0.1-5.0%). The growth dynamics of fibroblasts in culture was traced for the periods up to 144 h using the automated digital immersion confocal microscope. The study of the original sGAG mixture demonstrated the bimodal effect: low concentrations (0.1-0.5%) stimulated the proliferation of fibroblasts, while high concentrations (1-5%) possessed an antiproliferative effect. Changes of the form (solution or gel) had no effect on the functional properties of the mixture. High sGAG concentrations (3-5.0%), along with the antiproliferative effect, had a hidden weak cytotoxic action (a delayed effect).

Keywords

glycosaminoglycans (GAG) / corneal keratan sulfate / chondroitin sulfate / fibroblasts

Cite this article

Download citation ▾

Khristo Periklovich Takhchidi, Sergey Viktorovich Novikov, Anna Viktorovna Shatskikh, Elena Khristovna Takhchidi, Kseniya Sergeevna Gorbunova, Kh P Takhchidi, S V Novikov, A V Shatzkikh, Ye Kh Takhchidi, K S Gorbunova. FUNCTIONAL SIGNIFICANCE OF SULFATED GLYCOSAMINOGLYCAN COMPLEX FOR THE CONTROL OF FIBROBLAST PROLIFERATION IN VITRO. Morphology, 2012, 142(5): 49-54 DOI:10.17816/morph.398558

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Серов В. В. и Шехтер А. Б. Соединительная ткань. М., Медицина, 1981.

[2]	Ходжаев Н. С., Нерсесов Ю. Э. и Захидов А. Б. Антипролиферативный эффект локальной цитокинотерапии в экспериментальной модели антиглаукоматозной операции. В кн.: Материалы VIII Науч.-практ. конф. с междунар. участием «Федоровские чтения». М., 2009, с. 225-226.

[3]	Хорошилова-Маслова И. П., Ганковская Л. В., Андреева Е. Д. и др. Ингибирующее влияние комплекса цитокинов на заживление ран после глаукомофильтрующей операции в эксперименте. Вестн. офтальмол., 2000, № 1, с. 5-8.

[4]	Anisimov S. I., Anisimova S. Y. and Rogachova I. V. Angularuveal drainage with biological implant from osteal collagen with glycosaminoglycans and viscoelastic material for surgical treatment of refractory glaucoma. 6th Intern. Glaucoma Symp. Athens. 2007, Book of abstracts., р. 60.

[5]	Colwell A. S., Phan T. T., Kong W. et al. Hypertrophic scar fibroblasts have increased connective tissue growth factor expression after transforming growth factor-beta stimulation. Plast. Reconstr. Surg., 2005, v. 116, № 5, р. 1387-1390, disc. p. 1391-1392.

[6]	David G. Integral membrane heparan sulfate proteoglycans. FASEB J., 1993, v. 7, № 11, р. 1023-1030.

[7]	Grossfeld H., Meyer K., Godman G. and Linker A. Mucopolysaccharides produced in tissue culture. J. Biophys. Biochem. Cytol., 1957, v. 3, № 3, р. 391-396.

[8]	Kolset S. O., Prydz K. and Pejler G. Intracellular proteoglycans. Biochem J., 2004, v. 379, Pt 2, р. 217-227.

[9]	Kurtz M. J. and Stidworthy G. H. Control over acid mucopolysaccharide production of cells in vitro. Biochim. Biophys. Acta., 1975, v. 399, № 1, р. 90-100.

[10]	Syrokou A., Tzanakakis G., Tsegenidis T. et al. Effects of glycosaminoglycans on proliferation of epithelial and fibroblast human malignant mesothelioma cells: a structure-function relationship. Cell Prolif., 1999, v. 32, №2-3, р. 85-99.

[11]	Takhchidi K. P., Novikov S. V., Takhchidi E. K. and Shatskich A. V. Biomodal effect of sGAG action in vitro and in vivo consiclering a specific example of sclera wound healing. 17th Congr. Europ. Soc. Ophtalmol. Abstract book. Amsterdam, 2009, p. 14.

[12]	Tkachenko E., Rhodes J. M. and Simons M. Syndecans: new kids on the signaling block. Circ. Res., 2005, v. 96, № 5, р. 488-500.

[13]	Trowbridge J. M. and Gallo R. L. Dermatan sulfate: new functions from an old glycosaminoglycan. Glycobiology, 2002, v. 12, № 9, р. 117R-125R.

[14]	Volpi N. Therapeutic applications of glycosaminoglycans. Curr. Med. Chem., 2006, v. 13, № 15, р. 1799-1810.

[15]	Westergren-Thorsson G., Persson S., Isaksson A. et al. L-iduronate-rich glycosaminoglycans inhibit growth of normal fibroblasts independently of serum or added growth factors. Exp. Cell. Res., 1993, v. 206, № 1, р. 93-99.

[16]	Zhang Z., Li X. J., Liu Y. et al. Recombinant human decorin inhibits cell proliferation and downregulates TGF-beta1 production in hypertrophic scar fibroblasts. Burns, 2007, v. 33, № 5, р. 634-641.